MedTrace Logo

The Effect of Chloroquine in the Treatment of Patients With Dengue

NCT00849602 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2009-02-24

No results posted yet for this study

Summary

The objective of this study was to evaluate the effect of chloroquine in the treatment of patients with dengue.

Conditions

  • Dengue

Interventions

DRUG

Placebo

Placebo bid for three days

DRUG

Chloroquine

Chloroquine bid for three days

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

    collaborator OTHER_GOV

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Benedito AL Fonseca, PhD · São Paulo University Medical School at Ribeirão Preto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-05-31
Completion
2009-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00849602 on ClinicalTrials.gov